Stocks to Watch

MOBILE MEDIA UNLIMITED HOLDINGS INCORPORATED (OTC: MMUH)
"Up 104.17% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/MMUH.php

MMU is a leader in mobile marketing technologies, utilizing proprietary state-of-the-art marketing solutions and our unique ability to reach millions of new consumers simultaneously. With our extensive "opt in" inventory, MMU strives to stay ahead of the curve, giving our clients a seamless delivery solution and the highest quality of customer service.

MMUH News:

December 28 - MMU Holdings Inc. Definitive Agreement Executed With TzuFuma Inc.

Mobile Media Unlimited Holdings Inc. (OTC: MMUH) announced that the Company has executed the Definitive Agreement ("DA") with TzuFuma Inc. MMUH will purchase TzuFuma in an all stock transaction costing MMUH 58,000,000 shares of newly issued restricted common stock.

TzuFuma Inc. is a wholesale distributor business of Electronic Cigarettes. Electronic Cigarettes or E-Cigarettes are technological marvels which have the look, taste and feel of a real cigarette without any combustible components and produces water vapor instead of second-hand smoke. The advantages of this product are apparent since no actual smoke by-product is created, and users have the freedom to enjoy smoking in establishments currently smoker unfriendly.

Robert Paterson, President of TzuFuma Inc. stated in a telephone interview: "We have ironed out all of the remaining details regarding financing and the integration of the acquisition and I am pleased to announce that no significant material changes were made to the original MOI. The Company and its associates bring a wide talent pool to the table with skill sets we believe will immediately enhance marketing and accelerate our clients into mass distribution here in the United States but more importantly Internationally. We anticipate gross revenues from domestic sales to be in the region of 12-14% of our total gross revenue for fiscal 2010. We fully anticipate 2010 to be a bumper year."

SOMAXON PHARMACEUTICALS INCORPORATED (NASDAQ: SOMX)
"Up 81.82% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/SOMX.php

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. A New Drug Application (NDA) for Silenor® (doxepin), Somaxon’s drug candidate for insomnia, has been filed with the U.S. Food and Drug Administration and currently is under review.

SOMX News:

January 21 - Somaxon Provides Update on New Drug Application for Silenor® for the Treatment of Insomnia

Resubmission has been filed, with 2 month review cycle

Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

Somaxon held a meeting with senior leadership at the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the issues raised by the FDA in the Complete Response Letter Somaxon received in December 2009 relating to the Silenor NDA. The only remaining efficacy issue was related to the robustness of sustained subjective sleep maintenance efficacy in non-elderly adults with primary insomnia. In the meeting, the FDA and the company discussed this issue, and the agency instructed Somaxon to resubmit the contents of its January 20, 2010 pre-meeting briefing package to the FDA. The agency acknowledged that this resubmission would be considered a complete response to the Complete Response Letter Somaxon received in December. The FDA also agreed that this would be considered a Class 1 resubmission with a two-month review cycle. No additional safety or efficacy data was required to be included in the resubmission, and the company filed the resubmission with the FDA on January 21, 2010. As a result, the company anticipates a decision from the FDA by March 21, 2010.

“We believe that the dialogue we had with the FDA was constructive,” said Richard W. Pascoe, Somaxon’s president and chief executive officer. “We intend to continue to work diligently with the FDA during the two-month review cycle toward a potential approval for Silenor.”

In the meeting the FDA also reiterated that a revised Risk Evaluation and Mitigation Strategy (REMS), including a Medication Guide to be distributed with the product, will be required.

ABOUT SILENOR®

Silenor is a low-dose (3 mg, 6 mg) oral tablet formulation of doxepin hydrochloride that is patent protected for use in insomnia. Physicians have prescribed doxepin for more than 35 years for the treatment of depression and anxiety at dosages typically ranging from 75 mg to 300 mg per day. Based upon the controlled clinical trials of Silenor completed by Somaxon, the company believes that Silenor may be well tolerated by patients. In addition, the FDA has indicated that it will recommend that Silenor not be scheduled as a controlled substance.

SYMPOWERCO CORPORATION (OTC: SYMW)
"Up 75.00% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/SYMW.php

SymPowerco Corporation develops advanced fuel cell and power delivery systems for the rapidly growing personal transportation and portable power system markets being created by today's energy and environmental challenges.

SYMW News:

January 22 - SymPowerco Discusses Development Plans for 2010

SymPowerco Corporation (OTC: SYMW) CEO John Davenport announced that the company has completed a broad assessment of the current state of its technologies and of its various technical and business relationships with the objective of maximizing their values to shareholders.

As a result of the reviews, SymPowerco has developed a multi-faceted development plan for 2010, the details of which will be announced in the days and weeks ahead. The objectives of the plan will be the much more rapid development of the company's core technologies.

Stated CEO John Davenport, "During the last year, there have been many developments in various technologies, services and markets that are of great interest to SymPowerco. With the rebounding economy and the increasing interest in alternative energy and technologies, the company is planning to accelerate the development of its current technologies and to create new initiatives to expand our technology base and future commercial opportunities. Many initiatives are already underway and the company looks forward to presenting its plans to shareholders."

SymPowerco Corporation develops advanced fuel cell and power delivery systems for the rapidly growing personal transportation and portable power system markets that are being created by today's energy and environmental challenges.

BERGAMO ACQUISITION CORPORATION (OTC: BGMO)
"Up 40.00% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/BGMO.php

Bergamo Acquisition Corp., through its wholly owned subsidiary, Bergamo E&A Corp., focuses on the development of clean energy infrastructure projects in Pakistan. The company involves in the construction of mission-critical infrastructure, including clean energy electric plants, solar renewable energy projects, and LED high efficiency lighting projects. It also provides construction management and facility maintenance services. In addition, Bergamo Acquisition Corp. engages in wholesale business that focuses on women’s urban fashion apparel and accessories comprising recognized brands. The company is headquartered in Henderson, Nevada.

BGMO News:

January 15 - Bergamo Acquisition Corporation Updates Investors on the Funding Announced Tuesday

Bergamo Acquisition Corporation (OTC: BGMO) has received many inquiries regarding the timing of the funding for Tuesday's contract announcement. Most investors are asking when the Company expects to receive the initial $25 Million USD in the Company account and when to expect the remaining $75 Million USD in the account. The initial funding is imminent, and should be in the Bergamo Citibank account in Henderson, Nevada within about seven banking days from the contract signing on Monday, January 11, 2010. The Company received updated correspondence on Thursday confirming this. The remaining balance of $75 Million USD will be initiated at 22 days past the signing of the contract on Monday, and will also take a number of days for the international wire to be complete.

The Patriot Act in the United States, and similar laws around the world, requires due diligence on the part of regulators to assure that funds are legitimate in origin and will only be used for legitimate business purposes. This is absolutely standard operating procedures in international banking. This was expected and planned for on the part of all parties to this transaction. We intend to update investors through a press release once the funds are received.

HOP-ON INCORPORATED (OTC: HPNN)
"Up 25.71% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/HPNN.php

Hop-on (OTC: HPNN) develops and markets wireless phones and accessories for emerging market and other domestic carriers and is best known for developing the world's first disposable cell phone. Currently, Hop-on is expanding into value-added services, like mobile gambling and SMS wagering. Hop-on's exclusive software will allow users to stream live interactive feed from legal jurisdictions to play poker, blackjack, roulette and baccarat on personal cell phones. For more information, visit www.Hop-on.com.

HPNN News:

January 19 - FDA Has Green Light for USACIG and Hop-on Electronic Cigarettes Imports

USACIG, Inc. and Hop-on, Inc. (OTC: HPNN) hailed last Thursday's federal judge's ruling saying the Food and Drug Administration must stop interfering with importing electronic cigarettes. The judge also indicated the devices should be regulated as tobacco products, rather than drug or medical devices.

Jay Pignatello, President of USACIG, Inc., stated, "The smoking public is one of the largest marketplaces in the world, and smoking is a social activity. USACIG is coming to market at the best time. It is very simple -- USACIG is an American company. We produce our nicotine with American by-products. With all due respect to products made in China, you don't know what you are going to get. Our product lasts longer and tastes better. My dad smoked and I wish he had a product like this that avoided the side effects of tar in traditional tobacco. We are an American company, delivering an American product, through American intellectual property with American product development expertise. When you use our product, it is like driving a Chevy."

Pignatello continued, "USACIG is committed to being the top supplier of electronic cigarettes in the USA. We believe our product is the safest, best tasting, and least expensive in this marketplace, and will soon be available in a wide array of big box stores. Our relationship with Hop-on, combined with our experienced sales team, has us awaiting signed Letters of Intent, and our sales will increase exponentially. Additionally, we will soon be conducting a unique launch of our cigarettes to some specific retailers, at no cost to the public. Our goal is to deliver a brand name and product that everyone will be comfortable and familiar with."

Peter Michaels, President of Hop-on, stated, "Judge Leon's positive opinion helps us in there should be no government roadblocks to slow down our progress launching our products in the US. I have worked through issues with government bureaucracy before, and Judge Leon's decision should make my life easier. Our products virtually have none of the cancer-causing chemicals of traditional cigarettes, but the FDA says it has not been proven safe. Our goal with USACIG is prove our products are safe, affordable for everyone and profitable for our company. We experienced no issues importing our electronics into the US market. Our product is better, less expensive, and the technology behind our cigarettes is made in America."

With the passage of landmark tobacco legislation last year, Judge Leon added, the Food and Drug Administration's new tobacco division will be able to regulate the contents and marketing claims of e-cigarettes in the same way it is about to begin regulating traditional tobacco products. But the agency's drug division cannot ban the devices, the judge ruled.

ABOUT USACIG INC.

USACIG is the only US-based manufacturer making the actual nicotine cartridges/products in the US. The Electric Cigarette™ is an alternative to traditional tobacco products. It is a battery-powered device providing inhaled doses of nicotine by delivering vaporized water, propylene glycol, nicotine solution and other non-carcinogens. In addition to nicotine delivery, this vapor also provides a flavor and physical sensation similar to that of inhaled tobacco smoke, while no tobacco, smoke, or combustion is actually involved in its operation. USACIG, Inc. is a US-based manufacturer of "The Electric Cigarette" and "The Electric Cigar"™. USACIG manufactures its cartridges in the United States and the electronics are manufactured in China. USACIG also has US-based doctors on its board monitoring and supervising medical related issues or opportunities.

GOLDEN DRAGON HOLDINGS INCORPORATED (OTC: GDHI)
"Up 28.00% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/GDHI.php

Golden Dragon Holdings, Inc. (GDHI) is a USA publicly traded company that owns and operates Golden Dragon Food & Beverage Import & Export Company of Hong Kong, Ltd. (GDHK) in central Hong Kong. Golden Dragon Holdings, Inc. has agreements with USA food manufacturers. GDHI acts as a buying agent for GDHK, negotiating vendor contracts and services with USA food and beverage industry partners. The company purchases goods and services directly from Golden Dragon Holdings, Inc. The Hong Kong Company plays a strategic role in the importation of products into the Chinese market by leveraging the Closer Economic Partnership Arrangement (CEPA) with China. We distribute some of the most popular USA food and beverage brand products directly into the hypermarkets, supermarkets and convenience stores in China. We are responsible for order fulfillment for our clients in China, as well as providing advertising and promotion (A&P) services for our USA food and beverage products.

GDHI News:

January 22 - Golden Dragon Holdings, Inc. Release Copy of Its Year-End 2009 Conference Call

Golden Dragon Holdings, Inc. (OTC: GDHI), an international food and beverage distributor specializing in the Chinese market, announces that it has released an electronic copy of the conference call held on Thursday, January 21st. This file is available at http://www.gdfbhk.com/investors.html.

Mr. Frank Yglesias, CEO, & Mr. Cesar Cuenca, President, both stated, "We want to thank all the participants that dialed into our conference call line. We hope that we were able to answer everyone's questions, if there were any participants or shareholders that were unable to ask any questions please feel free to call the company at 888-889-8185 or email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it . Once again, we want to thank all our shareholders for the confidence that they have bestowed us."